A Randomized Trial of Liraglutide for High-Risk Heart Failure Patients With Reduced Ejection Fraction

Kenneth B Margulies, Univ of Pennsylvania, Philadelphia, PA; Kevin J Anstrom, Duke Univ, Philadelphia, PA; Margaret M Redfield, Mayo Clinic, Rochester, MN; Michael M Givertz, Brigham and Women's Hosp, Boston, MA; Guilherme H Oliveira, UH Case Medical Ctr, Cleveland, OH; Robert Cole, Emory Univ, Atlanda, GA; Doug Mann, Washington Univ in St. Louis, St. Louis, MO; David J Whellan, Thomas Jefferson Univ, Philadelphia, PA; Michael S Kiernan, Tufts Univ, Boston, MA; G. Michael Felker, Steven E McNulty, Duke Univ, Durham, NC; Monica R Shah, Natl Heart Lung and Blood Inst, Bethesda, MD; Adrian F Hernandez, Duke Univ, Durham, NC; Eugene Braunwald, Brigham and Women's Hosp, Boston, MA; Thomas P Cappola, Univ of Pennsylvania, Philadelphia, PA